Summary

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● Its low valuation, with P/E ratio at 8.67 and 7.41 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.6 for the 2023 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● The company is one of the best yield companies with high dividend expectations.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The opinion of analysts covering the stock has improved over the past four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.